APREMILAST
- Product NDC
- 60219-1410
- 11-digit product format
- 602191410
- Labeler code
- 60219
- Product ID
- 60219-1410_ee9b2224-736a-4dd1-8e8f-6795bf73300e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- APREMILAST
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA211782
- Marketing category
- ANDA
- Marketing start
- 2021-07-05
- Marketing end
- 0000-00-00
- Substance
- APREMILAST
- Active strength
- 30 mg/1
- Pharmacologic classes
- Phosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60219-1410 | APREMILAST KIT APREMILAST TABLET, FILM COATED [AMNEAL PHARMACEUTICALS NY LLC] | 8 | Legacy NDC | 20250223_6b37f813-113f-48f3-904c-7d14401ab13d.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60219-1410-6 | 60219141006 | 60 TABLET, FILM COATED in 1 BOTTLE (60219-1410-6) | 2021-07-05 | 0000-00-00 | No | No | Current |